George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 261.50
Bid: 261.60
Ask: 261.80
Change: 0.80 (0.31%)
Spread: 0.20 (0.076%)
Open: 262.20
High: 262.80
Low: 259.10
Prev. Close: 260.70
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 Mar 2024 15:07

RNS Number : 3853I
Marks and Spencer Group PLC
26 March 2024
 

Director/PDMR Shareholding

Marks and Spencer Group plc (the 'Company') announces that on 26 March 2024 it was notified of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs'):

 

1. Vesting of an award granted on 9 December 2022 (as previously announced by the Company) to Alex Freudmann under the Company's Restricted Share Plan, and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below. The Company requires Alex to have an equity position of 100% of salary within 5 years of appointment.

 

2. Vesting of an award granted on 21 March 2022 to Mark Lemming under the Company's Restricted Share Plan ('RSP'), and subsequent sale of shares to satisfy the tax and national insurance liabilities arising as set out below. The award was granted in lieu of a share award he would have received from his previous role with Kingfisher plc. The Company requires Mark to have an equity position equivalent to 100% of salary within 5 years of appointment.

 

 

PDMR

Shares vested on 25 March 2024

Shares sold to cover tax and NI

Shares retained by individual

1.

A Freudmann

398,997

189,038

209,959

2.

M Lemming

73,806

34,969

38,837

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulations.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

A Freudmann

2

Reason for the notification

a)

Position/status

PDMR (Managing Director of Food)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 1p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Vesting of 398,997 shares awarded under the RSP.

2. Subsequent sale of 189,038 shares acquired under the RSP award to cover the tax and NI liability, with 209,959 shares retained.

c)

Price(s) and volume(s)

1. Vesting

Price(s)

Volume(s)

£0.01

398,997

2. Sale

Price(s)

Volume(s)

£2.4977

189,038

d)

Aggregated information

-

Aggregated volume

-

Price

1. Vesting

Price(s)

Volume(s)

Total

£0.01

398,997

 £3,989.97

2. Sale

Price(s)

Volume(s)

Total

£2.4977

189,038

 £472,160.21

e)

Date of the transaction

2024-03-25

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

M Lemming

2

Reason for the notification

a)

Position/status

PDMR (Managing Director of International)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 1p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Vesting of 73,806 shares awarded under the RSP.

2. Subsequent sale of 34,969 shares acquired under the RSP award to cover the tax and NI liability, with 38,837 shares retained.

c)

Price(s) and volume(s)

1. Vesting

Price(s)

Volume(s)

£0.01

73,806

2. Sale

Price(s)

Volume(s)

£2.4977

34,969

d)

Aggregated information

-

Aggregated volume

-

Price

1. Vesting

Price(s)

Volume(s)

Total

£0.01

73,806

 £738.06

2. Sale

Price(s)

Volume(s)

Total

£2.4977

34,969

£87,342.07

e)

Date of the transaction

2024-03-25

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDXLGDDGSL
Date   Source Headline
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSTotal Voting Rights
2nd Jan 20249:00 amRNSBlock listing Interim Review
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:56 pmRNSHolding(s) in Company
6th Jun 202310:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.